abstract |
The present invention relates to pyrido[3,4-d]pyrimidine compounds of formula I suitable as kinase inhibitors, kinase inhibitors in prodrug form, their use in compositions and medicaments, said compositions and medicaments being suitable for use in For the treatment of diseases related to kinase activity, such as cancer. |